Harvard Bioscience's (HBIO) CEO Jeffrey Duchemin on Q4 2016 Results - Earnings Call Transcript

3/10/17

Harvard Bioscience, Inc. (NASDAQ:HBIO)

Q4 2016 Results Earnings Conference Call

March 9, 2017 4:30 p.m. ET

Executives

Corey Manchester - Director, Finance and Investor Relations

Jeffrey Duchemin - President and Chief Executive Officer

Robert Gagnon - Chief Financial Officer

Analysts

Raymond Myers - The Benchmark Company

Operator

Welcome to the Q4 2016 Harvard Bioscience Inc. Earnings Conference Call. My name is Ally and I will be your operator for today’s call. At this time all participants are in a listen only mode. Later, we will conduct a question-and-answer session. Please note that this conference is being recorded. I will now turn the call over to Corey Manchester, Director of Finance and Investor Relations. Corey, you may begin.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.